Table 2. Association between inflammatory biomarkers and atrial fibrillation diagnosed by ECG.

	Unadjusted OR	P-value	Adjusted OR†	P-value
ECG diagnosed AF at baseline
hs-CRP	1.15 (0.91–1.46)	0.24	1.12 (0.86–1.45)	0.40
Fibrinogen	1.12 (0.89–1.42)	0.33	1.06 (0.82–1.37)	0.66
TNF-α	1.22 (0.83–1.81)	0.31	1.01 (0.64–1.60)	0.9
IL-6	1.70 (1.36–2.12)	<0.0001	1.61 (1.21–2.14)	0.001
New-onset atrial fibrillation
hs-CRP	1.16 (1.00–1.35)	0.049	1.13 (0.96–1.33)	0.13
Fibrinogen	1.09 (0.93–1.27)	0.28	1.01 (0.86–1.18)	0.9
TNF-α	1.15 (0.89–1.48)	0.29	0.97 (0.73–1.28)	0.82
IL-6	1.37 (1.16–1.63)	0.0007	1.25 (1.02–1.53)	0.03

^† Adjusted for age, sex, race, body mass index, diabetes mellitus, smoking, history of CVD, echocardiographic parameters, SBP, eGFR, and use of Angiotensin converting enzyme inhibitor/Angiotensin receptor blocker [ACEi/ARB], antiplatelet agents, beta-blocker, calcium channel-blocker, diuretic, insulin, aspirin, and statins, and UACR and potassium.